Skip to main content
Premium Trial:

Request an Annual Quote

Steven Salzberg, Cliff Turner, Andrew Creasey, Donald Halbert, Graham Fleming, Pier Oddone, Janet Thornton, Ewan Birney

Premium

Steven Salzberg, senior director of bioinformatics at the Institute for Genomic Research, will be leaving his post this summer to serve as director of the center for bioinformatics and computational biology at the University of Maryland, according to BioInform, Pharmacogenomics Reporter's sister publication.


Cliff Turner has been appointed as president of NextGen Sciences Inc, the wholly owned US subsidiary of NextGen Sciences in the UK, the company said today. He replaces Andrew Creasey, who will remain a company consultant. Turner will operate NextGen's new US office in Illinois. Previously, he was director of sales and marketing development at Nanosphere and held positions at Affymetrix and Life Technologies, now part of Invitrogen. He has an undergraduate degree in biology from the University of Illinois and an MS degree in immunology and microbial genetics from Northern Illinois University.


Donald Halbert has joined Iconix Pharmaceuticals as executive vice president of research and development, the company said yesterday. He comes to Iconix from Abbott Laboratories, where he was director of genomics, proteomics, and bioinformatics in the global pharmaceutical research and development group. In addition, he was chairman of the Abbott-Iconix scientific advisory committee, overseeing the two companies' 2003 alliance. Previously, he held scientific and management positions at Becton Dickinson. Halbert has a PhD in molecular virology from Washington University in St. Louis.


Graham Fleming will be the new deputy director of Lawrence Berkeley National Laboratory, Berkeley Lab said last week. He will replace Pier Oddone, who will become director of the Fermi National Accelerator Laboratory in July. Fleming has been the lab's physical biosciences division director. He holds a PhD in chemistry from the University of London.


Janet Thornton has won this year's senior scientist accomplishment award and Ewan Birney the Overton prize from the International Society for Computational Biology, ISCB and the European Bioinformatics Institute said this week. Thornton, who has been director of EBI since 2001 as well as coordinator of the BioSapiens network of excellence, receives the award for outstanding and seminal research contributions to the field of structural bioinformatics. She is also the founding chief scientific officer of Inpharmatica.

 

Filed under

The Scan

Breast Cancer Risk Related to Pathogenic BRCA1 Mutation May Be Modified by Repeats

Several variable number tandem repeats appear to impact breast cancer risk and age at diagnosis in almost 350 individuals carrying a risky Ashkenazi Jewish BRCA1 founder mutation.

Study Explores Animated Digital Message Approach to Communicate Genetic Test Results to Family Members

In the Journal of Genetic Counseling, the approach showed promise in participants presented with a hypothetical scenario related to a familial hereditary breast and ovarian cancer syndrome diagnosis.

Computational Tool Predicts Mammalian Messenger RNA Degradation Rates

A tool called Saluki, trained with mouse and human messenger RNA data, appears to improve mRNA half-life predictions by taking RNA and genetic features into account, a Genome Biology paper reports.

UK Pilot Study Suggests Digital Pathway May Expand BRCA Testing in Breast Cancer

A randomized pilot study in the Journal of Medical Genetics points to similar outcomes for breast cancer patients receiving germline BRCA testing through fully digital or partially digital testing pathways.